A new vaccine for Lyme disease, a neurological and physically debilitating tick borne disease, has proved promising and well tolerated by patients, according to researchers. The Lyme vaccine is shown to produce substantial antibodies against all targeted species of Borrelia, the causative agent of Lyme disease.
